Literature DB >> 12234761

Calcium cycling, historic overview and perspectives. Role for autonomic nervous system regulation.

Natalia N Petrashevskaya1, Sheryl E Koch, Ilona Bodi, Arnold Schwartz.   

Abstract

The human heart proceeds from a relaxed state (diastole) to a fully contracted state (systole) and recovery in 600ms. During this period, Ca(2+) inside the myocardial cell rises from about 10nM to about 100nM and returns to the former. The contractile-relaxation cycle is tightly coupled to the Ca(2+)transient. In the normal physiological state, the autonomic nervous system (ANS) plays a major role in the regulation of cardiac function and important changes occur in diseases of the heart. Sympathetic overdrive is a major determinant of the critical transition from initial compensatory hypertrophy to decompensated failure. Cardiac myocytes from failing hearts are characterized by a number of abnormalities in excitation-contraction coupling, that are a direct consequence of beta-adrenergic signaling defects. Although desensitized in cardiac hypertrophy and failure, the beta-adrenergic signaling pathway retains receptor capacity, a characteristic that is used in therapeutic approaches. There are several putative Ca(2+)-dependent pathways that exert counterbalancing negative regulation over cAMP-dependent positive inotropic effect and may represent potential targets for contractile stimulation. This review is focused on the interactions between sympathetic drive and aspects of calcium signaling in the heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234761     DOI: 10.1006/jmcc.2002.2033

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

1.  Activation of protein kinase C in sensory neurons accelerates Ca2+ uptake into the endoplasmic reticulum.

Authors:  Yuriy M Usachev; Anthony J Marsh; Tanner M Johanns; Michelle M Lemke; Stanley A Thayer
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

2.  Reduced inhibitor 1 and 2 activity is associated with increased protein phosphatase type 1 activity in left ventricular myocardium of one-kidney, one-clip hypertensive rats.

Authors:  Ramesh C Gupta; Sudhish Mishra; Xiao-Ping Yang; Hani N Sabbah
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  β2 -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies.

Authors:  Mohamed H Shahin; Nihal El Rouby; Daniela J Conrado; Daniel Gonzalez; Yan Gong; Maximilian T Lobmeyer; Amber L Beitelshees; Eric Boerwinkle; John G Gums; Arlene Chapman; Stephen T Turner; Carl J Pepine; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  J Clin Pharmacol       Date:  2019-05-14       Impact factor: 3.126

4.  Adrenergic Receptor Regulation of Mitochondrial Function in Cardiomyocytes.

Authors:  Peyton B Sandroni; Kelsey H Fisher-Wellman; Brian C Jensen
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

5.  Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.

Authors:  Mohamed H Shahin; Daniela J Conrado; Daniel Gonzalez; Yan Gong; Maximilian T Lobmeyer; Amber L Beitelshees; Eric Boerwinkle; John G Gums; Arlene Chapman; Stephen T Turner; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  J Am Heart Assoc       Date:  2018-02-24       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.